Cargando…
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
Opioid agonists are well-established analgesics, widely prescribed for acute but also chronic pain. However, their efficiency comes with the price of drastically impacting side effects that are inherently linked to their prolonged use. To answer these liabilities, designed multiple ligands (DMLs) of...
Autores principales: | Gadais, Charlène, Piekielna-Ciesielska, Justyna, De Neve, Jolien, Martin, Charlotte, Janecka, Anna, Ballet, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434392/ https://www.ncbi.nlm.nih.gov/pubmed/34500841 http://dx.doi.org/10.3390/molecules26175406 |
Ejemplares similares
-
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors
por: Wtorek, Karol, et al.
Publicado: (2019) -
Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β(3)-Lysine
por: Wtorek, Karol, et al.
Publicado: (2021) -
Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors
por: Rupniak, Nadia M. J., et al.
Publicado: (2018) -
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2020) -
Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019)